Healthcare Market Research Reports & Industry Analysis

Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.

Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.

The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.

Publications found: 71,946

Sort by:

Schizoaffective Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Schizoaffective Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Schizoaffective Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule Typ...

May 2022 36 pages

Schwannoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Schwannoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Schwannoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides a...

May 2022 35 pages

Sciatica (Sciatic Pain) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Sciatica (Sciatic Pain) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Sciatica (Sciatic Pain) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type...

May 2022 37 pages

Sclerostin (SOST) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Sclerostin (SOST) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Sclerostin (SOST) Drugs in Development by Therapy Areas and Indications...

May 2022 39 pages

Seasonal Allergic Rhinitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Seasonal Allergic Rhinitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Seasonal Allergic Rhinitis Drugs in Development by Stages, Target, MoA, RoA, Molecule...

May 2022 47 pages

Seasonal Influenza Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Seasonal Influenza Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Seasonal Influenza Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Pl...

May 2022 92 pages

Secondary CNS Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Secondary CNS Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Secondary CNS Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type an...

May 2022 39 pages

Secondary Progressive Multiple Sclerosis (SPMS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Secondary Progressive Multiple Sclerosis (SPMS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Secondary Progressive Multiple Sclerosis (SPMS) Drugs in Develop...

May 2022 68 pages

Seizures Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Seizures Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Seizures Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an ov...

May 2022 127 pages

Semaphorin 3A (Semaphorin III or Collapsin 1 or Semaphorin D or Semaphorin L or SEMA3A) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Semaphorin 3A (Semaphorin III or Collapsin 1 or Semaphorin D or Semaphorin L or SEMA3A) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY S...

May 2022 36 pages

Sepsis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Sepsis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Sepsis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overvi...

May 2022 188 pages

Septic Shock Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Septic Shock Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Septic Shock Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provid...

May 2022 49 pages

Serine-Threonine Protein Kinase B Raf (p94 or Proto Oncogene B Raf or v Raf Murine Sarcoma Viral Oncogene Homolog B1 or BRAF or EC 2.7.11.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Serine-Threonine Protein Kinase B Raf (p94 or Proto Oncogene B Raf or v Raf Murine Sarcoma Viral Oncogene Homolog B1 or BRAF or EC 2.7.11.1) Drugs in Development by Therapy Areas and Indications, Stag...

May 2022 76 pages

Serine-Threonine Protein Kinase Chk1 (Checkpoint Kinase 1 or CHK1 Checkpoint Homolog or Cell Cycle Checkpoint Kinase or CHEK1 or EC 2.7.11.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Serine-Threonine Protein Kinase Chk1 (Checkpoint Kinase 1 or CHK1 Checkpoint Homolog or Cell Cycle Checkpoint Kinase or CHEK1 or EC 2.7.11.1) Drugs in Development by Therapy Areas and Indications, Sta...

May 2022 41 pages

Serine-Threonine Protein Kinase DCLK1 (Doublecortin Domain Containing Protein 3A or Doublecortin Like And CAM Kinase Like 1 or Doublecortin Like Kinase 1 or DCLK1 or EC 2.7.11.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Serine-Threonine Protein Kinase DCLK1 (Doublecortin Domain Containing Protein 3A or Doublecortin Like And CAM Kinase Like 1 or Doublecortin Like Kinase 1 or DCLK1 or EC 2.7.11.1) Drugs in Development...

May 2022 36 pages

Serine-Threonine Protein Kinase-Endoribonuclease IRE1 (Endoplasmic Reticulum To Nucleus Signaling 1 or Inositol Requiring Protein 1 or Ire1 Alpha or Endoribonuclease or ERN1 or EC 2.7.11.1 or EC 3.1.26.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Serine-Threonine Protein Kinase-Endoribonuclease IRE1 (Endoplasmic Reticulum To Nucleus Signaling 1 or Inositol Requiring Protein 1 or Ire1 Alpha or Endoribonuclease or ERN1 or EC 2.7.11.1 or EC 3.1.2...

May 2022 38 pages

Serine-Threonine Protein Kinase Pim (Pim Kinase or PIM or EC 2.7.11.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Serine-Threonine Protein Kinase Pim (Pim Kinase or PIM or EC 2.7.11.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Serine/Threonine P...

May 2022 55 pages

Serine-Threonine Protein Kinase SIK2 (Qin Induced Kinase or Salt Inducible Kinase 2 or Serine-Threonine Protein Kinase SNF1 Like Kinase 2 or SIK2 or EC 2.7.11.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Serine-Threonine Protein Kinase SIK2 (Qin Induced Kinase or Salt Inducible Kinase 2 or Serine-Threonine Protein Kinase SNF1 Like Kinase 2 or SIK2 or EC 2.7.11.1) Drugs in Development by Therapy Areas...

May 2022 38 pages

Serine-Threonine Protein Kinase SIK3 (Salt Inducible Kinase 3 or Serine-Threonine Protein Kinase QSK or SIK3 or EC 2.7.11.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Serine-Threonine Protein Kinase SIK3 (Salt Inducible Kinase 3 or Serine-Threonine Protein Kinase QSK or SIK3 or EC 2.7.11.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Mo...

May 2022 37 pages

Serum Albumin (ALB) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Serum Albumin (ALB) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Serum Albumin (ALB) Drugs in Development by Therapy Areas and Indicat...

May 2022 36 pages

Severe Combined Immune Deficiency (SCID) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Severe Combined Immune Deficiency (SCID) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Severe Combined Immune Deficiency (SCID) Drugs in Development by Stages...

May 2022 51 pages

Sezary Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Sezary Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Sezary Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players...

May 2022 57 pages

Short Transient Receptor Potential Channel 5 (Transient Receptor Protein 5 or TRPC5) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Short Transient Receptor Potential Channel 5 (Transient Receptor Protein 5 or TRPC5) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Shor...

May 2022 37 pages

Signal Transducer And Activator Of Transcription 3 (Acute Phase Response Factor or DNA Binding Protein APRF or STAT3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Signal Transducer And Activator Of Transcription 3 (Acute Phase Response Factor or DNA Binding Protein APRF or STAT3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule...

May 2022 95 pages

Signal Transducer And Activator Of Transcription 5 (STAT5) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Signal Transducer And Activator Of Transcription 5 (STAT5) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Signal Transducer And Activato...

May 2022 37 pages

Simplexvirus (HSV) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Simplexvirus (HSV) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Simplexvirus (HSV) Infections Drugs in Development by Stages, Target, MoA, RoA, Mo...

May 2022 113 pages

Sirtuin (SIRT or EC 2.3.1.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Sirtuin (SIRT or EC 2.3.1.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Sirtuin (SIRT or EC 2.3.1.) Drugs in Development by Therapy A...

May 2022 69 pages

Skin Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Skin Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Skin Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players...

May 2022 44 pages

Skin And Skin Structure Infections (SSSI) Caused By Bacteria Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Skin And Skin Structure Infections (SSSI) Caused By Bacteria Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Skin And Skin Structure Infections (SSSI) Caused By...

May 2022 56 pages

Skin And Skin Structure Infections (SSSI) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Skin And Skin Structure Infections (SSSI) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Skin And Skin Structure Infections (SSSI) Drugs in Development by Stag...

May 2022 65 pages

Skin And Soft Tissue Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Skin And Soft Tissue Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Skin And Soft Tissue Infections Drugs in Development by Stages, Target, MoA, RoA...

May 2022 43 pages

Skin Ulcers Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Skin Ulcers Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Skin Ulcers Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides...

May 2022 47 pages

Sleep Apnea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Sleep Apnea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Sleep Apnea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides...

May 2022 60 pages

Sleep Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Sleep Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Sleep Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players...

May 2022 135 pages

Small Intestine Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Small Intestine Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Small Intestine Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type an...

May 2022 46 pages

Smoking Cessation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Smoking Cessation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Smoking Cessation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Play...

May 2022 53 pages

Social Anxiety Disorder (SAD-Social Phobia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Social Anxiety Disorder (SAD-Social Phobia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Social Anxiety Disorder (SAD/Social Phobia) Drugs in Development by...

May 2022 39 pages

Sodium Channel Protein Type 8 Subunit Alpha (Voltage Gated Sodium Channel Subunit Alpha Nav1.6 or SCN8A) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Sodium Channel Protein Type 8 Subunit Alpha (Voltage Gated Sodium Channel Subunit Alpha Nav1.6 or SCN8A) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key...

May 2022 52 pages

Sodium Dependent Dopamine Transporter (DA Transporter or DAT or Solute Carrier Family 6 Member 3 or SLC6A3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Sodium Dependent Dopamine Transporter (DA Transporter or DAT or Solute Carrier Family 6 Member 3 or SLC6A3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and K...

May 2022 102 pages

Sodium Dependent Serotonin Transporter (5HT Transporter or 5HTT or Solute Carrier Family 6 Member 4 or SLC6A4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Sodium Dependent Serotonin Transporter (5HT Transporter or 5HTT or Solute Carrier Family 6 Member 4 or SLC6A4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type an...

May 2022 94 pages

Sodium-Glucose Cotransporter 1 (High Affinity Sodium-Glucose Cotransporter or Solute Carrier Family 5 Member 1 or SGLT1 or SLC5A1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Sodium-Glucose Cotransporter 1 (High Affinity Sodium-Glucose Cotransporter or Solute Carrier Family 5 Member 1 or SGLT1 or SLC5A1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, R...

May 2022 45 pages

Sodium-Glucose Cotransporter 2 (Low Affinity Sodium-Glucose Cotransporter or Solute Carrier Family 5 Member 2 or SGLT2 or SLC5A2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Sodium-Glucose Cotransporter 2 (Low Affinity Sodium-Glucose Cotransporter or Solute Carrier Family 5 Member 2 or SGLT2 or SLC5A2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, Ro...

May 2022 76 pages

Soft Tissue Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Soft Tissue Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Soft Tissue Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key...

May 2022 310 pages

Solute Carrier Family 2 Facilitated Glucose Transporter Member 1 (Glucose Transporter Type 1 Erythrocyte-Brain or GLUT1 or HepG2 Glucose Transporter or SLC2A1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Solute Carrier Family 2 Facilitated Glucose Transporter Member 1 (Glucose Transporter Type 1 Erythrocyte-Brain or GLUT1 or HepG2 Glucose Transporter or SLC2A1) Drugs in Development by Therapy Areas an...

May 2022 40 pages

Somatostatin Receptor Type 2 (SRIF1 or SSTR2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Somatostatin Receptor Type 2 (SRIF1 or SSTR2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Somatostatin Receptor Type 2 (SRIF1 or SSTR...

May 2022 43 pages

Somatostatin Receptor Type 5 (SSTR5) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Somatostatin Receptor Type 5 (SSTR5) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Somatostatin Receptor Type 5 (SSTR5) Drugs in Develo...

May 2022 45 pages

Spasmodic Torticollis (Cervical Dystonia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Spasmodic Torticollis (Cervical Dystonia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Spasmodic Torticollis (Cervical Dystonia) Drugs in Development by Stag...

May 2022 36 pages

Sphingosine 1-Phosphate Receptor (S1PR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Sphingosine 1-Phosphate Receptor (S1PR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Sphingosine 1-Phosphate Receptor (S1PR) Drugs in...

May 2022 69 pages

Spinal Cord Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Spinal Cord Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Spinal Cord Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and...

May 2022 146 pages

Spinal Stenosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Spinal Stenosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Spinal Stenosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players...

May 2022 36 pages

Filters

Clear all

Price

—

Date

—

Pages

—

Offers

33% OFF on “TCR-Based Antibody a...

Discount Offer from GMD Research

280

Special Offer from MP Advisors

Special Offer on Therapy Class R...